An international team of biologists urge careful use of technology in research and flag potential biosafety risks.
The use of gene-editing technology to create virus-resistant cassava plants could have serious negative ramifications, according to new research by plant biologists at the University of Alberta, the University of Liege in Belgium, and the Swiss Federal Institute of Technology. Their results show that attempts to genetically engineer the plants to fight off viruses, in fact resulted in the propagation of mutated viruses in controlled laboratory conditions.
“We concluded that because this technology both creates a selection pressure on the viruses to evolve more quickly, and also provides the viruses a means to evolve, it resulted in a virus mutant that is resistant to our interventions,” explained Devang Mehta, postdoctoral fellow in the Department of Biological Sciences. CRISPR-Cas9 is found in nature, where bacteria use it to defend against viruses, however the researchers found that the technology results in very different outcomes in plants—and researchers are stressing the importance of screening against these sorts of unintended results in the future.
The cassava plant, the object of the study, is a starchy root vegetable that is consumed for food throughout the tropics. Cassava is a primary staple crop grown in South America, Africa, and Asia, from which 1 billion people get most of their calories each day. Each year, cassava crops are plagued by cassava mosaic disease, which causes 20 per cent crop loss. It is the mosaic disease that Mehta and his colleagues endeavoured to engineer against.
Unsuccessful results
The researchers used a new gene-editing technology called CRISPR-Cas9 to attempt to design cassava plants that could cut the DNA of the mosaic virus and make the plants resistant to its damaging effects. Unfortunately, their results were not successful. To understand what happened, the team sequenced hundreds of viral genomes found in each plant.
“We discovered that the pressure that CRISPR-Cas9 applied to the virus probably encouraged it to evolve in a way that increased resistance to intervention,” said Mehta. Mehta hastens to add that CRISPR-Cas9 has many other applications in food and agriculture that do not pose the same risks.
The research team is keen to share their results with other scientists who are using CRISPR-Cas9 technology to engineer virus-resistant plants, and encourage these groups to test their plants to detect similar viral mutations.
“We need to do more research on these types of applications of CRISPR-Cas9 technology before we proceed with field testing” said Mehta. Mehta, a postdoctoral fellow with Professor Glen Uhrig, began this research during his PhD studies at the Swiss Federal Institute of Technology (ETH) in Zurich.
Learn more: Gene-editing technology may produce resistant virus in cassava plant
The Latest on: Gene editing caution
[google_news title=”” keyword=”gene editing caution” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gene editing caution
- Gene-Editing the Climate: Examining the Ethical and Practical Considerations of Bioengineering Solutionson May 10, 2024 at 12:05 am
Given the science fiction-like character of some of these emerging climate responses its essential that researchers be transparent and responsive to public attitudes.How engineering biology can help m ...
- CRISPR-based gene editing treatment shows promise for rare eye disorderon May 9, 2024 at 8:08 am
Researchers at Oregon Health & Science University used an experimental CRISPR-based gene editing treatment in participants with a rare eye disorder that causes low vision and blindness. The results ...
- Editas Medicine’s Innovative In Vivo Gene Editing Approach and Positive Clinical Trial Prospects Bolster Buy Ratingon May 9, 2024 at 3:26 am
Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...
- Team develops an epigenome editing toolkit to dissect the mechanisms of gene regulationon May 8, 2024 at 5:00 pm
In a study just published in Nature Genetics, scientists from the Hackett Group at EMBL Rome have developed a modular epigenome editing platform—a system ... the effects of specific chromatin marks on ...
- An epigenome editing toolkit to dissect the mechanisms of gene regulationon May 8, 2024 at 5:00 pm
A study from the Hackett group at EMBL Rome led to the development of a powerful epigenetic editing technology. The system unlocks the ability to precisely program chromatin modifications at any ...
- Controversial scientist says he’ll use gene editing to end HIV & Alzheimer’son May 8, 2024 at 3:18 pm
Right now, U.S. law and universal medical ethics state that gene editing should only be used on laboratory animals, in order to test whether the technology might be safe for humans. But if He is ...
- Michigan boy receives groundbreaking gene-editing treatment to restore visionon May 7, 2024 at 9:31 pm
An 11-year-old boy in Warren has made medical history. He is one of two children in the world to receive an experimental gene therapy procedure to restore vision.
- Invest In A Revolutionary Gene Therapy With CRISPR Therapeuticson April 30, 2024 at 10:25 am
CRISPR Therapeutics' Casgevy could generate significant shareholder value if proven to be successful. Learn why I am highly bullish on CRSP stock.
- Gene Therapy Newson April 27, 2024 at 5:00 pm
Gene-Editing Offers Hope for People With Hereditary Disorder Feb. 2, 2024 — A group of patients with a hereditary disorder have had their lives transformed by a single treatment of a ...
- Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCson April 22, 2024 at 9:30 am
Non-viral circular ssDNA delivery associated to TALEN® gene editing allows high levels of gene insertion in long-term repopulating HSPCs NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Cellectis ...
via Bing News